ATE322904T1 - Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält - Google Patents

Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält

Info

Publication number
ATE322904T1
ATE322904T1 AT01936384T AT01936384T ATE322904T1 AT E322904 T1 ATE322904 T1 AT E322904T1 AT 01936384 T AT01936384 T AT 01936384T AT 01936384 T AT01936384 T AT 01936384T AT E322904 T1 ATE322904 T1 AT E322904T1
Authority
AT
Austria
Prior art keywords
antioxidant
cell protection
composition
improved cell
hydrophilic
Prior art date
Application number
AT01936384T
Other languages
English (en)
Inventor
Fabio Soldati
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE322904T1 publication Critical patent/ATE322904T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01936384T 2000-05-25 2001-05-22 Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält ATE322904T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20694500P 2000-05-25 2000-05-25

Publications (1)

Publication Number Publication Date
ATE322904T1 true ATE322904T1 (de) 2006-04-15

Family

ID=22768614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936384T ATE322904T1 (de) 2000-05-25 2001-05-22 Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält

Country Status (12)

Country Link
US (2) US6627231B2 (de)
EP (1) EP1317272B1 (de)
JP (1) JP4750340B2 (de)
CN (1) CN1450905A (de)
AT (1) ATE322904T1 (de)
CA (1) CA2409688A1 (de)
DE (1) DE60118759T2 (de)
DK (1) DK1317272T3 (de)
ES (1) ES2261416T3 (de)
MX (1) MXPA02011528A (de)
PT (1) PT1317272E (de)
WO (1) WO2001089542A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0734166B2 (ja) * 1987-06-26 1995-04-12 三菱電機株式会社 数値制御装置のオフセット形状作成方法
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
MXPA02011528A (es) * 2000-05-25 2003-04-25 Pharmaton Sa Metodo para mejorar la proteccion celular.
US6670392B2 (en) * 2001-04-06 2003-12-30 Bioadvantex Pharma Inc. Compositions and methods for the prevention and treatment of human prostate cancer
JP2005526719A (ja) * 2002-02-15 2005-09-08 ディーエスエム アイピー アセッツ ビー．ブイ． 血管新生関連病状の治療および予防のための、リコペンを含む組成物
FR2836046B1 (fr) * 2002-02-15 2006-09-15 Marie Jose Touche Nouvelle application therapeutique d'un compose a : le butoforme ou scuroforme, associe au produit b : l'eugenol et au produit c : oxyde de zinc , additionne de lycopene
US20030162837A1 (en) * 2002-02-23 2003-08-28 Dugan Laura L. Carboxyfullerenes and methods of use thereof
GB0208081D0 (en) * 2002-04-09 2002-05-22 Boots Co Plc Skincare compositions and methods
EP1382327A1 (de) * 2002-07-17 2004-01-21 Cognis France S.A. Verfahren zum Schutz der Haut gegen die Alterung
EP1382326A1 (de) * 2002-07-17 2004-01-21 Cognis France S.A. Verfahren zum Schutz der Haut gegen die Alterung
US20040151794A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Method of improvement of blood circulation
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
US20050053560A1 (en) * 2003-09-05 2005-03-10 Pharmaton S.A Use of a composition containing extracts of Vitis vinifera and lycopersicum for protecting the skin
WO2005030228A2 (en) * 2003-09-27 2005-04-07 Pharmaton S.A. Use of a composition containing extracts of vitis vinifera and lycopersicum for protecting the skin
US20050100537A1 (en) * 2003-11-10 2005-05-12 Evans Gregory S. Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals
EP1550450A1 (de) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Blutumlauf verbesserndes Mittel
EP1718168A1 (de) * 2004-02-19 2006-11-08 Boehringer Ingelheim International Gmbh Zusammensetzung für die behandlung von chronischen venenproblemen, enthaltend einen extrakt von roten weinblättern und ein entzündungshemmendes mittel
AU2005304546B2 (en) * 2004-11-09 2011-07-21 Hill's Pet Nutrition, Inc. Use of antioxidants for gene modulation
DE102004063638A1 (de) * 2004-12-31 2006-07-13 Biosyn Arzneimittel Gmbh Selen-haltige Medikamente zur Prophylaxe oder Therapie von endothelialen Gefäßerkrankungen
AT501682A1 (de) 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung
US7250445B1 (en) * 2005-01-14 2007-07-31 Ehrenpreis Eli D Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders
JP2006265150A (ja) * 2005-03-23 2006-10-05 Kyoto Life Science Kenkyusho:Kk 抗酸化健康飲料水
JP2006298878A (ja) * 2005-04-25 2006-11-02 Kyoto Life Science Kenkyusho:Kk 抗癌剤障害予防剤
GB0515035D0 (en) * 2005-07-21 2005-08-31 Cambridge Theranostics Ltd Treatment of atherosclerotic conditions
ITMI20060712A1 (it) 2006-04-11 2007-10-12 Fond Irccs Istituto Di Ricovero E Cura ... Uso di aminaftone per la preparazione di un medicamento per il trattamento delle arteriopatie
KR20100014799A (ko) * 2007-01-17 2010-02-11 엔베쎄 뉴트라쇠틱 비지니스 컨썰팅 과일 및 야채를 함유하는 항산화 음식조성물, 그 제조 방법 및 용도
EP2005941A3 (de) * 2007-06-01 2009-04-01 Henkel AG & Co. KGaA Zellverjüngende Zusammensetzungen
DE102008025089A1 (de) * 2007-06-01 2009-03-05 Henkel Ag & Co. Kgaa Zellverjüngende Zusammensetzungen
DE102008012909A1 (de) * 2008-03-06 2009-09-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Flavonoidverbindungen für die Prophylaxe und Therapie ischämischer oder entzündlicher Herz- und Kreislauferkrankungen
CN101569414B (zh) * 2008-04-29 2013-04-10 安琪酵母股份有限公司 一种富含酵母硒和酵母葡聚糖的组合物
CN102727872B (zh) * 2012-07-13 2014-09-24 威海百合生物技术股份有限公司 一种抗衰老、保护心血管软胶囊及其制备方法
DE102013013029A1 (de) * 2013-08-05 2015-02-05 Ernst Fekete Lobbyist-Zellschutz PNI (Psychoneuroimmunium)
EP2952104A1 (de) 2014-06-05 2015-12-09 Böhm, Kirsten Zusammensetzung und Verfahren zur Vermeidung von Beschädigungen von menschlichen Zellen durch ionisierende Strahlung
CN105942492A (zh) * 2016-04-28 2016-09-21 北京珍生康业生物科技有限公司 一种增强细胞膜抗氧化能力的葡番硒胶囊及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090414A (en) * 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
FR2721516B1 (fr) * 1994-06-27 1996-09-13 Inst Rech Biolog Sa Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.
FR2727018B1 (fr) * 1994-11-17 1997-01-31 Jcb Cosmetiques Composition orale pour la prevention des allergies solaires a base d'un carotenoide, d'un tocopherol, d'acide ascorbique et de selenium
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
EP1021177A4 (de) * 1997-02-04 2002-05-15 John V Kosbab Zusammensetzungen und verfahren zur verhütung und behandlung von vaskulär-degeneratieve krankheiten
EP0996431B1 (de) 1997-06-19 2004-03-31 Lycored Natural Products Industries Ltd Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
FR2782642B1 (fr) * 1998-08-31 2001-12-07 Xavier Forceville Utilisation du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs), et composition pour la mise en oeuvre du traitement
FR2792831B1 (fr) * 1999-04-28 2001-08-03 Bionatec Sarl Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier
FR2799345B1 (fr) * 1999-10-12 2001-12-07 Gervais Danone Sa Composition alimentaire ou dietetique contenant plusieurs antioxydants
MXPA02011528A (es) * 2000-05-25 2003-04-25 Pharmaton Sa Metodo para mejorar la proteccion celular.

Also Published As

Publication number Publication date
US20020012715A1 (en) 2002-01-31
EP1317272A2 (de) 2003-06-11
JP2003534285A (ja) 2003-11-18
DK1317272T3 (da) 2006-08-14
US6627231B2 (en) 2003-09-30
JP4750340B2 (ja) 2011-08-17
MXPA02011528A (es) 2003-04-25
EP1317272B1 (de) 2006-04-12
WO2001089542A2 (en) 2001-11-29
CN1450905A (zh) 2003-10-22
US6835401B2 (en) 2004-12-28
DE60118759D1 (de) 2006-05-24
PT1317272E (pt) 2006-06-30
DE60118759T2 (de) 2006-09-14
WO2001089542A3 (en) 2002-11-28
ES2261416T3 (es) 2006-11-16
US20040009248A1 (en) 2004-01-15
CA2409688A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
ATE322904T1 (de) Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält
WO2003041636A3 (en) Topical cosmetic composition with skin rejuvenation benefits
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
SE9900519D0 (sv) A method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof
WO2004007679A3 (en) Dendritic cell pontentiation
EP1072254A4 (de) Nahrungsmittel, orale zusammensetzungen und medizinische zusammensetzungn zur verhinderung oder behandlung von periodontosis und verfahren zur verhinderung oder behandlung von periodontosis
WO2006068786A3 (en) Compositions and methods of their use for improving the condition and appearance of skin
WO2002047706A3 (en) Selective cox-2 inhibition from plant extracts
WO2001080870A3 (en) Compositions derived from cranberry and grapefruit and therapeutic uses therefor
DE60227068D1 (de) Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen
WO2003011239A3 (en) Sunscreen composition
NO20035076D0 (no) Farmasöytiske og kosmetiske sammensetninger mot elding av huden
WO2009132174A3 (en) Methods and compositions for improving the nutritional content of mushrooms and fungi
EP1183954A4 (de) Ausbleichinhibitoren
CA2623777A1 (en) Compositions comprising hypsizygus ulmarius extract
TW200607529A (en) Natural sunscreen composition
AU2001275659A1 (en) Extracts from sophora species, method for producing the same and their use
EP4089094A4 (de) Tricyclisches tetrahydroisochinolinderivat, herstellungsverfahren dafür und anwendung davon in der medizin
AU2003232722A1 (en) Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity
WO2001032160A3 (en) Modification of cholesterol concentrations with citrus phytochemicals
WO2003057141A3 (en) Methods for improving the aesthetic appearance of skin
AU2003206691A1 (en) Optical arrangement, optical grid for use in an optical arrangement and method for the production of one such optical lattice
AU2003236817A1 (en) Plant extracts
ATE329604T1 (de) Verwendung einer antioxidativen zusammensetzung enthaltend einen extrakt aus mozuku-algen
ATE254912T1 (de) Sonnenschutzmittel zur oralen aufnahme

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1317272

Country of ref document: EP